Table 5.

Change in liver enzymes at 1 day and 1 month in 219 patients undergoing transarterial chemoembolization for hepatocellular carcinoma.

Total bilirubin serum level
Variable	TB < 2 (n = 179)	TB 2–3 (n = 30)	TB > 3 (n = 10)	P-value
Change AST, 1 day (U/L)	4.4 ± 8 [0.1–65.9]	1.8 ± 1.7 [0.2–10.1]	2.8 ± 3.1 [0.8–11.8]	0.5
Change ALT, 1 day (U/L)	2.9 ± 5.2 [0.1–60.7]	1.6 ± 1.7 [0.2–11.8]	2 ± 1.9 [0.8–7.4]	0.1
Change AST, 1 month (U/L)	1.2 ± 1.2 [0–13]	0.9 ± 0.3 [0–1.3]	1.1 ± 0.3 [0.8–1.6]	0.32
Change ALT, 1 month (U/L)	1.1 ± 1.6 [0.1–18.3]	0.8 ± 0.3 [0–1.7]	0.8 ± 0.3 [0.13–1.2]	0.47
Direct bilirubin serum level
Variable	DB < 1 (n = 197)	DB 1–2 (n = 17)		P-value
Change AST, 1 day (U/L)	3.7 ± 6.1 [0.1–65.9]	2.3 ± 2.8		0.36 [0.9–11.8]
Change ALT, 1 day (U/L)	2.6 ± 5.1 [0.1–60.7]	2.3 ± 3.0		0.85 [0.7–11.8]
Change AST, 1 month (U/L)	1.1 ± 1.0 [0–13]	1.0 ± 0.4		0.79 [0–1.7]
Change ALT, 1 month (U/L)	1.0 ± 1.3 [0.1–18.3]	0.8 ± 0.4		0.59 [0–1.6]

AST: aspartate aminotransferase; ALT: alanine transaminase; TB: total bilirubin; DB: direct bilirubin. Quantitative variables are expressed as mean ± standard deviations, followed by ranges in brackets.